Squarepoint
OPNT

Squarepoint’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Squarepoint’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,087
Closed -$90K – 3376
2020
Q3 		$90K Buy
+12,087
New +$107K ﹤0.01% 2306

Other funds holding OPNT

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint's OPNT Position: Q4 2020 in Review

Squarepoint sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2020, closing a stake of 12,087 shares — an estimated $90K sold.

Squarepoint first reported a position in OPNT in Q3 2020 and held it in 1 quarter. The position peaked at $90K in Q3 2020. 29 funds tracked by Wall St. Rank hold OPNT as of Q4 2020.

  • Squarepoint reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 12,087 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2020, an estimated $90K.
  • Squarepoint first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Squarepoint's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $90K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.